The neurovascular catheters market size has grown rapidly in recent years. It will grow from $4.87 billion in 2025 to $5.38 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising incidence of neurovascular disorders, increased adoption of minimally invasive neurosurgeries, growing availability of interventional neuroradiology services, advancements in catheter material science, expansion of stroke treatment centers.
The neurovascular catheters market size is expected to see rapid growth in the next few years. It will grow to $8.17 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to increasing demand for thrombectomy procedures, rising aging population with cerebrovascular risks, growing investments in neurointerventional technologies, expansion of advanced imaging-assisted interventions, increasing preference for minimally invasive brain therapies. Major trends in the forecast period include increasing adoption of steerable micro catheters, rising use of minimally invasive neurovascular procedures, growing demand for advanced embolization catheters, expansion of image-guided catheter navigation, enhanced focus on device flexibility and precision.
The growth of the neurovascular catheter market is anticipated to be driven by the increasing aging population. An aging population signifies a demographic change marked by a growing percentage of elderly individuals in society over time. Neurovascular catheters are essential for addressing various neurological conditions that are more common among older adults. For example, the Population Reference Bureau, a US-based nonprofit organization that specializes in collecting and providing statistics, projected in January 2024 that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Furthermore, the proportion of the population aged 65 and older is expected to grow from 17% to 23%. Thus, the increasing aging population is a key factor driving the neurovascular catheter market.
Major companies operating in the neurovascular catheter market are concentrating on the development of advanced solutions, such as balloon guide catheters (BGCs), to improve procedural support, distal navigation, and treatment accuracy in neurovascular interventions. A balloon guide catheter is a medical device used in interventional neuroradiology and neurointerventional surgery to enable the safe and effective management of cerebrovascular conditions, including stroke. For example, in March 2023, Q’Apel Medical Inc., a United States-based neurovascular device company, received CE Mark approval for its Walrus® Balloon Guide Catheter. Featuring a 0.087-inch inner diameter, the device offers enhanced proximal stability, improved distal trackability, and compatibility with complex stroke procedures, thereby supporting improved procedural outcomes and informed clinical decision-making. Q’Apel Medical focuses on developing high-precision neurovascular devices to advance interventional treatment options.
In October 2023, Integer Holdings Corporation, a United States-based contract development and manufacturing organization (CDMO), acquired substantially all the assets of InNeuroCo, Inc. for $44.5 million. Through this acquisition, Integer seeks to strengthen its neurovascular catheter capabilities by incorporating InNeuroCo’s differentiated designs and advanced manufacturing technologies, while broadening its portfolio of solutions for the treatment of stroke and intracranial aneurysms. InNeuroCo, Inc. is a United States-based company specializing in complex neurovascular catheters, including access guide catheter designs, prototype-to-volume manufacturing, and innovative delivery systems.
Major companies operating in the neurovascular catheters market are Medtronic plc, Stryker Corporation, Penumbra Inc., Johnson & Johnson, Terumo Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, Concentric Medical Inc., Raumedic AG, Olympus Corporation, B. Braun Melsungen AG, Imperative Care Inc., Balt LLC, Phenox GmbH, Teleflex Incorporated, MicroVention Inc., Boston Scientific Corporation, Cook Medical LLC, Cordis Corporation, Merit Medical Systems Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Abbott Laboratories.
North America was the largest region in the neurovascular catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurovascular catheters market by increasing costs of imported polymers, precision tubing, coatings, sensors, and manufacturing equipment used in micro, balloon, and embolization catheters. Hospitals and device manufacturers in North America and Europe are most affected due to dependence on globally sourced high-precision components, while Asia-Pacific faces pricing pressure on export-oriented catheter production. These tariffs are raising device prices and increasing procurement costs for healthcare providers. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic neurovascular device production capabilities.
The neurovascular catheters market research report is one of a series of new reports that provides neurovascular catheters market statistics, including neurovascular catheters industry global market size, regional shares, competitors with a neurovascular catheters market share, detailed neurovascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the neurovascular catheters industry. This neurovascular catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurovascular catheters serve as medical devices employed in the treatment of neurological conditions and diseases. They enable access to neurovascular organs and facilitate the delivery of embolic coils and thrombectomy devices. These devices are integral in minimally invasive procedures targeting blood vessel disorders within the brain, eliminating the need for incisions into the skull or brain tissue by manually inserting catheters through the patient's femoral or brachial arteries, guiding them to the brain for treatment.
Key types of neurovascular catheters include micro catheters, balloon catheters, access catheters, and embolization catheters. Micro catheters, with diameters typically ranging from 0.7 to 1.30mm, are utilized in intricate endovascular procedures for guidewire support, navigating complex vasculature, delivering therapeutic embolic materials, injecting contrast media, and performing other minimally invasive operations. These catheters find applications in treating conditions such as embolic stroke, brain aneurysms, arteriovenous malformations, and more. They are used across various healthcare settings including hospitals, clinics, ambulatory surgical centers, and diagnostic facilities.
The neurovascular catheters market consists of sales of occlusion catheters, stent delivery catheters, diagnostic catheters, guiding catheters, and distal access catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurovascular catheters market size is expected to see rapid growth in the next few years. It will grow to $8.17 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to increasing demand for thrombectomy procedures, rising aging population with cerebrovascular risks, growing investments in neurointerventional technologies, expansion of advanced imaging-assisted interventions, increasing preference for minimally invasive brain therapies. Major trends in the forecast period include increasing adoption of steerable micro catheters, rising use of minimally invasive neurovascular procedures, growing demand for advanced embolization catheters, expansion of image-guided catheter navigation, enhanced focus on device flexibility and precision.
The growth of the neurovascular catheter market is anticipated to be driven by the increasing aging population. An aging population signifies a demographic change marked by a growing percentage of elderly individuals in society over time. Neurovascular catheters are essential for addressing various neurological conditions that are more common among older adults. For example, the Population Reference Bureau, a US-based nonprofit organization that specializes in collecting and providing statistics, projected in January 2024 that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Furthermore, the proportion of the population aged 65 and older is expected to grow from 17% to 23%. Thus, the increasing aging population is a key factor driving the neurovascular catheter market.
Major companies operating in the neurovascular catheter market are concentrating on the development of advanced solutions, such as balloon guide catheters (BGCs), to improve procedural support, distal navigation, and treatment accuracy in neurovascular interventions. A balloon guide catheter is a medical device used in interventional neuroradiology and neurointerventional surgery to enable the safe and effective management of cerebrovascular conditions, including stroke. For example, in March 2023, Q’Apel Medical Inc., a United States-based neurovascular device company, received CE Mark approval for its Walrus® Balloon Guide Catheter. Featuring a 0.087-inch inner diameter, the device offers enhanced proximal stability, improved distal trackability, and compatibility with complex stroke procedures, thereby supporting improved procedural outcomes and informed clinical decision-making. Q’Apel Medical focuses on developing high-precision neurovascular devices to advance interventional treatment options.
In October 2023, Integer Holdings Corporation, a United States-based contract development and manufacturing organization (CDMO), acquired substantially all the assets of InNeuroCo, Inc. for $44.5 million. Through this acquisition, Integer seeks to strengthen its neurovascular catheter capabilities by incorporating InNeuroCo’s differentiated designs and advanced manufacturing technologies, while broadening its portfolio of solutions for the treatment of stroke and intracranial aneurysms. InNeuroCo, Inc. is a United States-based company specializing in complex neurovascular catheters, including access guide catheter designs, prototype-to-volume manufacturing, and innovative delivery systems.
Major companies operating in the neurovascular catheters market are Medtronic plc, Stryker Corporation, Penumbra Inc., Johnson & Johnson, Terumo Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, Concentric Medical Inc., Raumedic AG, Olympus Corporation, B. Braun Melsungen AG, Imperative Care Inc., Balt LLC, Phenox GmbH, Teleflex Incorporated, MicroVention Inc., Boston Scientific Corporation, Cook Medical LLC, Cordis Corporation, Merit Medical Systems Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Abbott Laboratories.
North America was the largest region in the neurovascular catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurovascular catheters market by increasing costs of imported polymers, precision tubing, coatings, sensors, and manufacturing equipment used in micro, balloon, and embolization catheters. Hospitals and device manufacturers in North America and Europe are most affected due to dependence on globally sourced high-precision components, while Asia-Pacific faces pricing pressure on export-oriented catheter production. These tariffs are raising device prices and increasing procurement costs for healthcare providers. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic neurovascular device production capabilities.
The neurovascular catheters market research report is one of a series of new reports that provides neurovascular catheters market statistics, including neurovascular catheters industry global market size, regional shares, competitors with a neurovascular catheters market share, detailed neurovascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the neurovascular catheters industry. This neurovascular catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurovascular catheters serve as medical devices employed in the treatment of neurological conditions and diseases. They enable access to neurovascular organs and facilitate the delivery of embolic coils and thrombectomy devices. These devices are integral in minimally invasive procedures targeting blood vessel disorders within the brain, eliminating the need for incisions into the skull or brain tissue by manually inserting catheters through the patient's femoral or brachial arteries, guiding them to the brain for treatment.
Key types of neurovascular catheters include micro catheters, balloon catheters, access catheters, and embolization catheters. Micro catheters, with diameters typically ranging from 0.7 to 1.30mm, are utilized in intricate endovascular procedures for guidewire support, navigating complex vasculature, delivering therapeutic embolic materials, injecting contrast media, and performing other minimally invasive operations. These catheters find applications in treating conditions such as embolic stroke, brain aneurysms, arteriovenous malformations, and more. They are used across various healthcare settings including hospitals, clinics, ambulatory surgical centers, and diagnostic facilities.
The neurovascular catheters market consists of sales of occlusion catheters, stent delivery catheters, diagnostic catheters, guiding catheters, and distal access catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurovascular Catheters Market Characteristics
3. Neurovascular Catheters Market Supply Chain Analysis
4. Global Neurovascular Catheters Market Trends and Strategies
5. Neurovascular Catheters Market Analysis of End Use Industries
7. Global Neurovascular Catheters Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurovascular Catheters Total Addressable Market (TAM) Analysis for the Market
9. Neurovascular Catheters Market Segmentation
10. Neurovascular Catheters Market Regional and Country Analysis
11. Asia-Pacific Neurovascular Catheters Market
12. China Neurovascular Catheters Market
13. India Neurovascular Catheters Market
14. Japan Neurovascular Catheters Market
15. Australia Neurovascular Catheters Market
16. Indonesia Neurovascular Catheters Market
17. South Korea Neurovascular Catheters Market
18. Taiwan Neurovascular Catheters Market
19. South East Asia Neurovascular Catheters Market
20. Western Europe Neurovascular Catheters Market
21. UK Neurovascular Catheters Market
22. Germany Neurovascular Catheters Market
23. France Neurovascular Catheters Market
24. Italy Neurovascular Catheters Market
25. Spain Neurovascular Catheters Market
26. Eastern Europe Neurovascular Catheters Market
27. Russia Neurovascular Catheters Market
28. North America Neurovascular Catheters Market
29. USA Neurovascular Catheters Market
30. Canada Neurovascular Catheters Market
31. South America Neurovascular Catheters Market
32. Brazil Neurovascular Catheters Market
33. Middle East Neurovascular Catheters Market
34. Africa Neurovascular Catheters Market
36. Neurovascular Catheters Market Competitive Landscape and Company Profiles
37. Neurovascular Catheters Market Other Major and Innovative Companies
40. Neurovascular Catheters Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neurovascular Catheters Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurovascular catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurovascular catheters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurovascular catheters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Micro catheters; Balloon Catheters; Access Catheters; Embolization Catheters; Other Types2) By Application: Embolic Stroke; Brain Aneurysm; Arteriovenous Malformations; Other Applications
3) By End-Use: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Centers
Subsegments:
1) By Micro Catheters: Steerable Micro Catheters; Non-steerable Micro Catheters2) By Balloon Catheters: Distal Balloon Catheters; Proximal Balloon Catheters
3) By Access Catheters: Diagnostic Access Catheters; Interventional Access Catheters
4) By Embolization Catheters: Soft Embolization Catheters; Stiff Embolization Catheters
5) By Other Types: Coil Catheters; Reinforced Catheters; Hydrophilic Catheters
Companies Mentioned: Medtronic plc; Stryker Corporation; Penumbra Inc.; Johnson & Johnson; Terumo Corporation; Acandis GmbH; Spiegelberg GmbH & Co. KG; Concentric Medical Inc.; Raumedic AG; Olympus Corporation; B. Braun Melsungen AG; Imperative Care Inc.; Balt LLC; Phenox GmbH; Teleflex Incorporated; MicroVention Inc.; Boston Scientific Corporation; Cook Medical LLC; Cordis Corporation; Merit Medical Systems Inc.; Rapid Medical Ltd.; Vascular Solutions Inc.; W. L. Gore & Associates Inc.; Abbott Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurovascular Catheters market report include:- Medtronic plc
- Stryker Corporation
- Penumbra Inc.
- Johnson & Johnson
- Terumo Corporation
- Acandis GmbH
- Spiegelberg GmbH & Co. KG
- Concentric Medical Inc.
- Raumedic AG
- Olympus Corporation
- B. Braun Melsungen AG
- Imperative Care Inc.
- Balt LLC
- Phenox GmbH
- Teleflex Incorporated
- MicroVention Inc.
- Boston Scientific Corporation
- Cook Medical LLC
- Cordis Corporation
- Merit Medical Systems Inc.
- Rapid Medical Ltd.
- Vascular Solutions Inc.
- W. L. Gore & Associates Inc.
- Abbott Laboratories
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.38 Billion |
| Forecasted Market Value ( USD | $ 8.17 Billion |
| Compound Annual Growth Rate | 11.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
